India’s pharmaceutical industry, valued at around US$58 billion, is projected to reach US$120-130 billion by 2030 and US$400-450 billion by 2047. Growth is driven by rising lifestyle diseases, an aging population, increased focus on holistic health, and the growing consumerization of healthcare. India allows 100 percent FDI under automatic approval for greenfield investments and up to…
